Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

34.95p
   
  • Change Today:
      0.050p
  • 52 Week High: 71.80
  • 52 Week Low: 34.05
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 237,540
  • Market Cap: £188.87m
  • RiskGrade: 119

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
31-Jan-24 RBC Capital Markets Outperform 37.55p 65.00p 60.00p Reiteration
26-Sep-23 Peel Hunt Limited Hold 48.40p - 53.00p Reiteration
25-May-23 Berenberg Bank Buy 62.30p - 105.00p Reiteration
25-May-23 Numis Buy 62.30p - 105.00p Reiteration
13-Sep-17 Investec Securities Buy 52.75p - 59.00p New Coverage
13-Sep-17 N 1 Singer Not Rated 52.75p - - Reiteration
18-Jul-17 Numis Securities Buy 52.50p - 60.00p Reiteration
09-May-17 FinnCap Buy 49.00p - 65.00p Reiteration
13-Jul-15 Canaccord Genuity Hold 45.00p 40.00p 40.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 34.95p
Change Today 0.050p
% Change 0.14 %
52 Week High 71.80
52 Week Low 34.05
Volume 237,540
Shares Issued 540.40m
Market Cap £188.87m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.29% above the market average84.29% above the market average84.29% above the market average84.29% above the market average84.29% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average
3.57% above the sector average3.57% above the sector average3.57% above the sector average3.57% above the sector average3.57% above the sector average
Income
11.89% above the market average11.89% above the market average11.89% above the market average11.89% above the market average11.89% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 16,597 @ 34.95p
16:35 485 @ 34.95p
16:35 148 @ 34.95p
16:35 251 @ 34.95p
16:35 148 @ 34.95p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page